Showing results (101-110 of 139) with videos related to
Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2022
Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma PatientsWen Zhang, Caifeng Gong, Xuenan Peng, et al.European Radiology|September 23, 2023
Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECISTYing Xu, Yi Yang, Jingzhong Ouyang, et al.BMC Cancer|March 16, 2020
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studiesXinan Sheng, Jie Jin, Zhisong He, et al.Therapeutic Advances in Medical Oncology|December 30, 2025
Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIsCaifeng Gong, Jinglong Huang, Dandan Cao, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 23, 2019
Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortalityWenzheng Guo, Min Hu, Jingjing Wu, et al.Journal for Immunotherapy of Cancer|January 29, 2026
PD-L1 expression on circulating tumor cells for predicting clinical outcomes in patients with hepatocellular carcinoma receiving PD-(L)1 blockade and targeted therapyCaifeng Gong, Shuhui You, Qi Zhang, et al.Scientific Reports|August 4, 2016
Reversible lysine acetylation is involved in DNA replication initiation by regulating activities of initiator DnaA in Escherichia coliQiufen Zhang, Aiping Zhou, Shuxian Li, et al.La Radiologia Medica|January 5, 2024
The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapyYi Yang, Lu Li, Ying Xu, et al.Hepatology (Baltimore, Md.)|May 1, 2022
Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysisJun Zhou, Yongkun Sun, Wen Zhang, et al.Current Microbiology|January 21, 2010
Molecular characterisation of the faecal microbiota in patients with type II diabetesXiaokang Wu, Chaofeng Ma, Lei Han, et al.Pageof 14